MedTrace Logo

Nutritional Status and Enteral Absorption Capability After Brain Death

NCT00858390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2014-06-26

Study results available
· View outcomes & findings →

Summary

The investigators propose to assess 36 donors' nutritional status using accepted parameters (prealbumin, resting energy expenditure); to assess nutrient intestinal absorption through 13Curacil breath tests; and to evaluate serum concentrations of IL-6 and TNFalpha to determine if continuing or initiating enteral feeding and nutritional supplementation is effective in restoring or maintaining nutritional parameters.

Conditions

  • Brain Death

Interventions

DIETARY_SUPPLEMENT

enteral feeding with Oxepa® and Glutasolve®

enteral feeding with Oxepa® and RESOURCE® GLUTASOLVE®

Sponsors & Collaborators

  • Health Resources and Services Administration (HRSA)

    collaborator FED

  • Baylor College of Medicine

    collaborator OTHER

  • LifeGift

    collaborator UNKNOWN

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Georgene Hergenroeder, MHA, RN · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-08-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00858390 on ClinicalTrials.gov